Media Summary: Prof Patrick Serruys (Imperial College London, London, UK) discusses Prof Patrick Serruys (Imperial College London, London, UK) discusses SURTAVI - One year outcomes of patients with severe ... Join the opinion leaders as they provide an expert summary of all the key learnings and findings from

Europcr 2018 Syntax Iii Revolution - Detailed Analysis & Overview

Prof Patrick Serruys (Imperial College London, London, UK) discusses Prof Patrick Serruys (Imperial College London, London, UK) discusses SURTAVI - One year outcomes of patients with severe ... Join the opinion leaders as they provide an expert summary of all the key learnings and findings from And finally F. Ribichini, D. Capodanno, and C. Cook assess the potential implications of Prof Jose Luis Navia (Cleveland Clinic, Cleveland, US) discusses early clinical experience of NaviGate transcatheter tricuspid ... Prof Elmir Omerovic (University of Gothenburg, SE) discusses SCAAR - Long-term survival in patients with stable angina pectoris ...

Dr Giulio Stefanini (Humanitas Research Hospital, Milan, IT) discusses FREE-FUTURE - First direct comparison between ... Results from the physiology-stratified analysis of the ORBITA presented at Nicolas van Mieghem & Roberto Diletti wrap up analyse the late-breaking trials at the Dr Nicolas van Mieghem and Dr Roberto Diletti (Thoraxcenter, Erasmus MC, Rotterdam, NL) present a data update on FFR ...

Photo Gallery

EuroPCR 2018: SYNTAX III Revolution - Prof Patrick Serruys
EuroPCR 2018: SYNTAX II - Prof Patrick Serruys
Syntax III Revolution - Scientific session at EuroPCR 2017
EuroPCR 2018: SURTAVI - Prof Patrick Serruys
EuroPCR 2018 Highlights of interventional cardiology
EuroPCR 2018 Highlights - Coronary Interventions
EuroPCR 2018: Early clinical experience of NaviGate in transcatheter tricuspid valve replacement
EuroPCR 2018: SCAAR - Prof Elmir Omerovic
EuroPCR 2018: FREE-FUTURE - Dr Giulio Stefanini
What makes EuroPCR unique?
The ORBITA trial - EuroPCR 2018
Wrap Up Of EuroPCR 2018 - An Analysis Of The Late-Breaking Trials
View Detailed Profile
EuroPCR 2018: SYNTAX III Revolution - Prof Patrick Serruys

EuroPCR 2018: SYNTAX III Revolution - Prof Patrick Serruys

Prof Patrick Serruys (Imperial College London, London, UK) discusses

EuroPCR 2018: SYNTAX II - Prof Patrick Serruys

EuroPCR 2018: SYNTAX II - Prof Patrick Serruys

Prof Patrick Serruys (Imperial College London, London, UK) discusses

Syntax III Revolution - Scientific session at EuroPCR 2017

Syntax III Revolution - Scientific session at EuroPCR 2017

The

EuroPCR 2018: SURTAVI - Prof Patrick Serruys

EuroPCR 2018: SURTAVI - Prof Patrick Serruys

Prof Patrick Serruys (Imperial College London, London, UK) discusses SURTAVI - One year outcomes of patients with severe ...

EuroPCR 2018 Highlights of interventional cardiology

EuroPCR 2018 Highlights of interventional cardiology

Join the opinion leaders as they provide an expert summary of all the key learnings and findings from

EuroPCR 2018 Highlights - Coronary Interventions

EuroPCR 2018 Highlights - Coronary Interventions

And finally F. Ribichini, D. Capodanno, and C. Cook assess the potential implications of

EuroPCR 2018: Early clinical experience of NaviGate in transcatheter tricuspid valve replacement

EuroPCR 2018: Early clinical experience of NaviGate in transcatheter tricuspid valve replacement

Prof Jose Luis Navia (Cleveland Clinic, Cleveland, US) discusses early clinical experience of NaviGate transcatheter tricuspid ...

EuroPCR 2018: SCAAR - Prof Elmir Omerovic

EuroPCR 2018: SCAAR - Prof Elmir Omerovic

Prof Elmir Omerovic (University of Gothenburg, SE) discusses SCAAR - Long-term survival in patients with stable angina pectoris ...

EuroPCR 2018: FREE-FUTURE - Dr Giulio Stefanini

EuroPCR 2018: FREE-FUTURE - Dr Giulio Stefanini

Dr Giulio Stefanini (Humanitas Research Hospital, Milan, IT) discusses FREE-FUTURE - First direct comparison between ...

What makes EuroPCR unique?

What makes EuroPCR unique?

EuroPCR 2018

The ORBITA trial - EuroPCR 2018

The ORBITA trial - EuroPCR 2018

Results from the physiology-stratified analysis of the ORBITA presented at

Wrap Up Of EuroPCR 2018 - An Analysis Of The Late-Breaking Trials

Wrap Up Of EuroPCR 2018 - An Analysis Of The Late-Breaking Trials

Nicolas van Mieghem & Roberto Diletti wrap up analyse the late-breaking trials at the

EuroPCR 2018: FFR SEARCH - Dr Nicolas Van Mieghem & Dr Roberto Diletti

EuroPCR 2018: FFR SEARCH - Dr Nicolas Van Mieghem & Dr Roberto Diletti

Dr Nicolas van Mieghem and Dr Roberto Diletti (Thoraxcenter, Erasmus MC, Rotterdam, NL) present a data update on FFR ...